- Home
- KA
KA
Kineta Inc.
as 07-26-2024 4:00pm EST
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | MERCER ISLAND |
| Market Cap: | 8.5M | IPO Year: | N/A |
| Target Price: | $8.00 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.50 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.33 - $5.39 | Next Earning Date: | 08-09-2024 |
| Revenue: | $5,161,000 | Revenue Growth: | 186.56% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Kineta Inc. (KA)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Bartoszek Raymond J. | KA | Director | Dec 4 '23 | Buy | $4.33 | 1,000 | $4,325.00 | 15,956 | SEC Form 4 |
| Bartoszek Raymond J. | KA | Director | Dec 4 '23 | Buy | $4.50 | 1,000 | $4,500.00 | 16,956 | SEC Form 4 |
| Bartoszek Raymond J. | KA | Director | Dec 4 '23 | Buy | $4.50 | 250 | $1,125.00 | 17,206 | SEC Form 4 |
| Iadonato Shawn | KA | Chief Executive Officer | Nov 28 '23 | Buy | $3.33 | 900 | $2,995.02 | 671,130 | SEC Form 4 |
| Iadonato Shawn | KA | Chief Executive Officer | Nov 28 '23 | Buy | $3.51 | 4,100 | $14,402.89 | 675,230 | SEC Form 4 |
Latest Kineta Inc. News
KA Breaking Stock News: Dive into KA Ticker-Specific Updates for Smart Investing
MT Newswires
19 days ago
Kineta Enters Into $5 Million Agreement With TuHURA Biosciences for Vista Blocking Immunotherapy; Shares Rise
GlobeNewswire
19 days ago
Kineta Announces Exclusivity and Right of First Offer Agreement for its VISTA blocking antibody with TuHURA Biosciences
Business Wire
2 months ago
Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition
GlobeNewswire
2 months ago
Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus
GlobeNewswire
2 months ago
Share buy-back programme - week 23
Simply Wall St.
2 months ago
Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?
Reuters
2 months ago
Japan's service sector mood hits nearly 2-year low in May
AFP
2 months ago
N. Korea sends more balloons as Kim's sister warns of 'new counteraction'
Compare KA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "KA Kineta Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.